Assessment and Evaluation of the Safe Childbirth Checklist –Phase II

Overview

PHFI independently evaluated the effectiveness of the Safe Childbirth Checklist program in preventing stillbirths and early neonatal deaths. Evaluation used a quasi-experimental design with data collection from 34 facilities across six intervention districts and four control districts. The study with a sample of 137,000 births has 88% power to detect 15% reduction in intrapartum mortality. Data on this was collected over a period of 17 months (November 2013 to April 2015).

Full Title of Study: “Assessment and Evaluation of the Safe Childbirth Checklist –Phase II Rajasthan, India”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Non-Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Prevention
    • Masking: None (Open Label)
  • Study Primary Completion Date: September 2015

Detailed Description

The Safe Childbirth Checklist (SCC), a tool that provides reminders and is a job aid to health care providers is a new maternal and newborn care intervention that is being implemented by the Government of Rajasthan with technical support from Jhpeigo. SCC is thus expected to improve the quality of delivery care practices and was implemented in Community Health Centres (CHCs) and District Hospitals (DHs) across seven districts in Rajasthan over a two-year time period (2013 to 2015). PHFI independently evaluated the effectiveness and cost-effectiveness of the SCC in preventing intrapartum (stillbirths and very early neonatal deaths within 3-days after births). Data on 137,000 births was collected over a period of 17 months (November 2013 to April 2015) from 34 facilities with sick newborn care centres (SNC). Facility records were main source of outcome data. Labor room provided data on stillbirths whereas information on very early neonatal deaths came from SNCs. All Data collection and management was done through software specifically developed for this purpose. For a better understanding on how maternal and neonatal complications are diagnosed and managed at the facility, in-depth interviews were conducted with the service providers (specialists, physicians, labor room staff nurses, and pharmacists) from the District hospitals and CHCs. In addition, interviews focused on understanding the use, acceptability and feasibility of the SCC among various types of providers. Cost of this intervention was estimated from a program perspective, and cost effectiveness in terms of cost per perinatal death prevented was calculated. Preliminary analysis has found that SCC is significantly associated with a 11% reduction in intrapartum deaths. Permission for this study and data collection has been obtained from the Department of Health and Family Welfare, Government of Rajasthan.

Interventions

  • Behavioral: SCC
    • The intervention involves introducing and orienting health providers on the SCC, facilitating availability of a specific set of commodities and regular targeted supervision. These are expected to improve adherence to life saving interventions immediately before, during and after birth, and reduce intrapartum mortality (still births and very early neonatal deaths).

Arms, Groups and Cohorts

  • No Intervention: No safe childbirth checklist
    • The selected control districts include Bharatpur, Pali, Jhunjhunu, and Nagaur
  • Active Comparator: Safe Childbirth Checklist
    • The selected districts for SCC intervention include Alwar, Jalore, Sirohi, Sikar, Dausa, and Churu

Clinical Trial Outcome Measures

Primary Measures

  • Perinatal mortality
    • Time Frame: 18 months (Nov-2013 to May-2015)
    • This evaluation will independently estimate the effectiveness of the Safe Childbirth Checklist in reduce perinatal mortality by 15% in the intervention areas

Secondary Measures

  • Morbidity rates for infants and mothers
    • Time Frame: 18 months (Nov-2013 to May-2015)
    • We determine checklist-related morbidity rates for infants and mothers at the intervention facilities by observing the following: Level of Practices -use of partograph or recording of events; active management of third stage labor (AMTSL); early initiation of breast feeding; use of antihypertensives/magnesium sulphate for mothers and use of antibiotics for mother and neonate Levels of neonatal morbidity (low birth weight/prematurity, asphyxia, sepsis), maternal morbidity (Post partum haemorrhage, sepsis, eclampsia etc)

Participating in This Clinical Trial

Inclusion Criteria

  • All women who deliver at the District Hospitals (DHs), Sub-District Hospitals (SDHs) and Community Health Centres (CHCs) Exclusion Criteria:

-

Gender Eligibility: Female

Minimum Age: 15 Years

Maximum Age: 50 Years

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Public Health Foundation of India
  • Collaborator
    • UBS Optimus Foundation
  • Provider of Information About this Clinical Study
    • Principal Investigator: Dr. Beena Varghese, Sr. Health Economist and Additional Professor – Public Health Foundation of India
  • Overall Official(s)
    • Beena Varghese, PhD, Principal Investigator, Public Health Foundation of India

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.